Biosimilar Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Real World Study

BACKGROUND AND PURPOSE: There is an unmet need for a more effective thrombolytic agent in acute ischemic stroke (AIS) management. Various studies and meta-analysis suggest tenecteplase (TNK) as non-inferior over alteplase (rTPA). The present single-center study compares biosimilar TNK and rTPA in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Ayush, Komakula, Snigdha, Murali, Suhas, Anand, Pooja, Shah, Dyuti, Vishnu, VY, Pandit, Awadh Kishor, Agarwal, Ayush, Vibha, Deepti, Singh, Mamta Bhushan, Padma Srivastava, MV, Bhatia, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081554/
https://www.ncbi.nlm.nih.gov/pubmed/37034051
http://dx.doi.org/10.4103/aian.aian_754_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081554/
https://www.ncbi.nlm.nih.gov/pubmed/37034051
http://dx.doi.org/10.4103/aian.aian_754_22

Ejemplares similares